TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -5 | -14 | -10 | -37 | -32 | -16 |
| S | %wins | 50 | 100 | 100 | 50 | 100 | 50 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/3/12 17:48 | 2/3/12 | PGNX | Progenics Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Briner Kurt W | NY | D | S | -337 | 10.22 | 1 | -33 | -100 | 0 | D | 132 | 77 | 72 | 63 | 20 | 15 | 7 | 5 | 1 | 0 | -10 | 2 | -53 | -70 | |
5/17/11 15:26 | 5/13/11 | PGNX | Progenics Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Briner Kurt W | NY | D | S.m | -165 | 8.25 | 1 | -20 | -38 | 33 | D | 52 | 47 | 75 | 41 | 33 | 12 | 10 | 1 | -4 | -9 | -17 | -22 | -21 | 6 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |